Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Sezzle Inc — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $57.06 (market cap $25.27B), while Sezzle Inc trades at $126 (market cap $3.95B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 6.4× Sezzle Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Sezzle Inc for 15 Days on average.
| RPRX | SEZL | |
|---|---|---|
Market Cap | $25.27B | $3.95B |
Volume | 3,671,183 | 550,075 |
Sector | Health | Financials |
52-Week High | $63.96 | $188.55 |
52-Week Low | $35.44 | $50.97 |
Typical Hold Time | 1 Days | 15 Days |
Enterprise Value | $32.50B | $3.99B |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sezzle (SEZL) surged 9.98% to $125.21, reflecting strong momentum after consistently beating earnings estimates. The stock shows bullish technical signals with robust fundamentals including 51.7% revenue growth in Q2 2026 and exceptional profitability metrics (ROE 88.85%, net margin 30.35%). Recent product launches like Sezzle Send and SezzleCash are driving user growth and platform engagement.
Outlook remains positive with 35% revenue growth guidance and 35.9% upside to consensus price target of $168. Key risks include BNPL competition and potential credit quality concerns, but strong institutional buying and analyst optimism support the bullish case for continued growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
